 |
|
TargeGen, Inc., formed in 2001, is a privately held biopharmaceutical company based in San Diego, CA. The company develops small molecule kinase inhibitors for the treatment of cancer, pulmonary, ocular and certain other diseases.
|
| ::Read
More |
|
 |
 |
 |
May 14th
TargeGen Announces Successful Completion of Patient Enrollment In Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients And Scheduled Presentation of Preliminary Trial Data At EHA Conference in Berlin
|
| ::Read More |
|
 |
|
For more information, please see
www.clinicaltrials.gov |
| ::Read More |
|
